These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16000079)

  • 1. Population proteomics: addressing protein diversity in humans.
    Nedelkov D
    Expert Rev Proteomics; 2005 Jun; 2(3):315-24. PubMed ID: 16000079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population proteomics: investigation of protein diversity in human populations.
    Nedelkov D
    Proteomics; 2008 Feb; 8(4):779-86. PubMed ID: 18210367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-content affinity-based proteomics: unlocking protein biomarker discovery.
    Brody EN; Gold L; Lawn RM; Walker JJ; Zichi D
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1013-22. PubMed ID: 21080818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance proteomics as a tool in biomarker discovery.
    Meyer HE; Stühler K
    Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry.
    Powell DW; Merchant ML; Link AJ
    Expert Rev Proteomics; 2006 Feb; 3(1):63-74. PubMed ID: 16445351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures.
    Fox JW; Serrano SM
    Proteomics; 2008 Feb; 8(4):909-20. PubMed ID: 18203266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population proteomics: the concept, attributes, and potential for cancer biomarker research.
    Nedelkov D; Kiernan UA; Niederkofler EE; Tubbs KA; Nelson RW
    Mol Cell Proteomics; 2006 Oct; 5(10):1811-8. PubMed ID: 16735302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches.
    Kiernan UA
    Expert Rev Proteomics; 2007 Jun; 4(3):421-8. PubMed ID: 17552926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. So, you want to look for biomarkers (introduction to the special biomarkers issue).
    LaBaer J
    J Proteome Res; 2005; 4(4):1053-9. PubMed ID: 16083254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes.
    Roe MR; Griffin TJ
    Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of a current role of mass spectrometry for proteome research.
    Chen CH
    Anal Chim Acta; 2008 Aug; 624(1):16-36. PubMed ID: 18706308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of capillary electrophoresis-mass spectrometry to proteome analysis and biomarker discovery.
    Ahmed FE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1963-81. PubMed ID: 19525156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.